For the quarter ending 2026-03-31, NVNO had -$468K decrease in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
| Net loss | -3,849 | -3,736 | -15,736 |
| Stock-based compensation | 467 | 637 | 2,783 |
| Depreciation and amortization | 31 | 31 | 105 |
| Loss on disposition of property and equipment | -4 | - | - |
| Amortization of right-of-use assets | 93 | 86 | 267 |
| Unrealized loss from investments | -43 | -79 | -312 |
| Prepaid expenses and other current assets | -55 | 67 | -34 |
| Accounts payable, accrued expenses and other current liabilities | 15 | -382 | 383 |
| Operating lease liabilities | -97 | -91 | -273 |
| Net cash used in operating activities | -3,238 | -3,443 | -12,125 |
| Maturities of investments | 25,012 | 23,498 | 38,381 |
| Purchases of property and equipment | - | 0 | 5 |
| Purchases of investments | 22,242 | 19,316 | 26,702 |
| Net cash provided by investing activities | 2,770 | 4,182 | 11,674 |
| Proceeds from sale of common stock in at-the-market offering, net of fees | - | 782 | - |
| Proceeds from exercise of warrants | - | 0 | 241 |
| Net cash provided by financing activities | - | 782 | 241 |
| Net (decrease) increase in cash and cash equivalents | -468 | 1,521 | -210 |
| Cash and cash equivalents, beginning of period | 3,065 | 1,544 | 1,754 |
| Cash and cash equivalents, end of period | 2,597 | 3,065 | 1,544 |
enVVeno Medical Corp (NVNO)
enVVeno Medical Corp (NVNO)